Scholarly Index
Douglas Mogul
SciClone Pharmaceuticals (United States); 1,506 total citations; 90 total publications; best world rank #515
SciClone Pharmaceuticals (United States)
1,506Total citations
90Total publications
21H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Pediatric Hepatobiliary Diseases and Treatments | 2021-2025 | 670 | US 143 | 83.52 |
| Intestinal Malrotation and Obstruction Disorders | 2021-2025 | 515 | US 143 | 64.98 |